Lactobacillus gasseri
- Generic Name
- Lactobacillus gasseri
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- Q66E0D2443
- Associated Conditions
- Vaginal Flora Imbalance
- Associated Therapies
- -
Synbiotics in patients at risk for spontaneous preterm birth: protocol for a multi-centre
Pregnant women at risk for sPTB will be randomized to receive synbiotics or placebo from 8-10 weeks gestation until delivery. The synbiotic contains eight Lactobacillus strains, inulin, FOS, and D-mannose. Adherence will be monitored via diaries, and standard care protocols for sPTB prevention will be followed. Primary outcomes include gestational age at delivery and PTB rates, with secondary outcomes covering neonatal and microbiome analyses.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath